Please upgrade your browser.
According to a new study, men employed in occupations with potential exposure to high levels of sunlight have a reduced risk of kidney cancer compared with men who were less likely to be exposed to sunlight at work. The study did not find an association between occupational sunlight exposure and kidney cancer risk in women. Published early online in CANCER, a peer-reviewed journal of the American Cancer Society, the study is the largest case-control study of kidney cancer to investigate the association with occupational sunlight exposure.
Abstracts: Renal Cell Cancer. Complete information is available on this website: http://www.gucasymposium.org.
As the use of robotics in urology expands beyond the prostate gland, short-term results on robotic partial nephrectomy for stage T1 renal masses show promising oncologic and intraoperative outcomes.
Christopher G. Wood, MD, FACS - M. D. Anderson Cancer Center: Some have called into question whether cytoreductive nephrectomy still should be incorporated in the treatment of patients with metastatic disease.
The phosphatidylinositol 3-kinase (PI3K) signaling axis impacts on cancer cell growth, survival, motility, and metabolism. This pathway is activated by several different mechanisms in cancers, including somatic mutation and amplification of genes encoding key components.
Merit Awards recognize the work of oncology fellows who are first authors on outstanding Symposium abstracts. The following fellows have received Merit Awards for their research. Edwin Jason Abel, MD M. D. Anderson Cancer Center Does targeted therapy result in reliable and meaningful primary tumor downstaging in patients with metastatic renal cell carcinoma? (Abstract 318) Renal Cell Cancer Oral Abstract Session C
Blacks with renal cell cancer (RCC) have lower survival rates than whites. While comorbidities, socioeconomic factors, and access to healthcare are suggested to contribute to differences in survival, the effects of race on histology and stage of the RCC have not been studied. We analyzed data from the Surveillance, Epidemiology, and End Results (SEER) database to evaluate the influence of race on histology and stage of RCC.
Frontline sunitinib has been shown to produce a high response rate (RR), and improved progression-free survival (PFS) and overall survival (OS) in patients (pts) with clear cell RCC (ccRCC). Retrospective data suggest sunitinib may be effective in papillary and chromophobe RCC.
The KCA's Facebook Challenge encourages people to become members of the organization's Facebook Fan Page, and then invite others to join. According to Bro, "This helps our charity to easily disseminate information about cutting-edge kidney cancer therapies to patients..."
|Powered by NeonCRM|